Piromed

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Piromed

Property Description
Active Ingredient Piroxicam
Form Capsules, tablets, injection, topical preparations (gel/cream)
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Common Use Symptomatic relief of persistent inflammatory conditions and associated pain
Origin Synthetic compound (Oxicam derivative)

What is Piromed and What Type of Drug Is It?

Piromed is a prescription-only medication classified globally as a Nonsteroidal Anti-Inflammatory Drug (NSAID), a group of synthetic agents used to manage discomfort, swelling, and elevated body temperature. Its active compound is Piroxicam, which is chemically defined as a synthetic compound belonging to the oxicam derivative family. Piroxicam is used for its efficacy in suppressing inflammatory responses.

Piroxicam was the first substance licensed in the oxicam series and is an enolic acid derivative. This classification is significant as it underpins the drug's sustained action profile. The core function of Piroxicam is to reduce substances in the body associated with pain and inflammation.

Active Ingredient, Composition, and Available Forms

The therapeutic effect of Piromed is solely provided by its single-ingredient product, Piroxicam, compounded with inert excipients to create the final medicinal form. A differentiating factor for Piroxicam is its long half-life compared to many other NSAIDs, meaning it is often clinically recognized for maintaining stable concentrations over a longer period.

Piroxicam is made available across multiple dosage forms, often including oral solid forms such as capsules and tablets, as well as solutions for injection (parenteral administration) and topical preparations such as gels and creams. Piroxicam possesses anti-inflammatory, analgesic, and antipyretic properties. The medication is characterized by its triple action against inflammation, pain, and fever, regardless of the physical form used.

General Therapeutic Purpose

The overarching general purpose of Piromed is to provide broad symptomatic relief by intervening in the body's inflammatory response pathways. This establishes the medicine as an effective anti-inflammatory agent, analgesic, and antipyretic. A typical use scenario involves managing discomfort associated with conditions where persistent inflammation is a primary feature. By targeting the biochemical processes that drive pain and swelling, the drug helps to diminish these physical manifestations, establishing its role in reducing symptoms related to inflammation and fever without curing the underlying condition.

Regulatory References

  1. Piroxicam: MedlinePlus Drug Information

What side effects are possible with Piromed?

Possible Side Effects and Safety Information

The safety profile of Piromed (Piroxicam), an NSAID, is structured by government regulatory agencies through classifications based on physiological systems, frequency, and severity. The medicine is associated with risks across multiple organ systems, with serious adverse reactions explicitly documented for the gastrointestinal and cardiovascular systems.

Key Adverse Reactions and Frequencies

Adverse reactions are formally classified by incidence:

  • Most Common: Reactions frequently documented in clinical use include gastrointestinal discomfort (nausea, constipation, diarrhea, abdominal pain), headache, dizziness, and edema (fluid retention).
  • Common: Reactions may include somnolence, vertigo, and a sensation of ringing in the ears (tinnitus).
  • Very Rare: This category includes documented serious cutaneous adverse reactions (SCARs), such as Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and fatal hepatic events.

Serious Adverse Reactions

Regulatory documents list adverse events classified as serious and potentially life-threatening:

System Serious Adverse Reactions
Gastrointestinal Bleeding, ulceration, and perforation of the stomach or intestines.
Cardiovascular Serious thrombotic events, including myocardial infarction and stroke.
Dermatological Severe bullous skin reactions (SJS, TEN) and DRESS.

Population and Exposure-Related Safety Notes

The official labeling notes specific safety considerations. Older adults are documented as being at an increased risk for serious gastrointestinal and cardiovascular thrombotic events. Furthermore, the risk of serious cardiovascular events may begin as early as the first weeks of treatment, and doses greater than 20 mg per day carry an increased risk of gastrointestinal adverse effects. Regulatory constraints also prohibit use in patients known to have experienced asthma or hives following exposure to aspirin or other NSAIDs due to documented allergic cross-sensitivity.

Overdose and Emergency Response

The official regulatory profile for Piromed (Piroxicam) documents specific clinical manifestations associated with overdosage. Overexposure may be evidenced by gastrointestinal distress, including nausea, vomiting, and epigastric pain, alongside central nervous system effects such as dizziness, headache, and somnolence. Due to the potential for severe complications, regulatory guidance mandates that users seek immediate medical attention or contact emergency services upon suspicion of overdosage or the onset of severe symptoms. The most serious risks are tied to the potential for potentially fatal organ injury, which includes acute renal failure, hepatic damage, serious cardiovascular thrombotic events (such as myocardial infarction or stroke), and severe gastrointestinal ulceration or perforation. Management is officially restricted to symptomatic and supportive treatment as no specific antidote is known for Piroxicam overdosage. Procedures such as gastric lavage or the administration of activated charcoal may be considered for recent ingestion. Close monitoring of vital signs and organ function, including renal, hepatic, and cardiac status, is required. Elderly patients are noted to be at increased risk for serious gastrointestinal adverse events.

Therapeutic Uses of Piromed

This category of medicine is generally used to relieve symptoms across key domains of discomfort and heightened physiological activity. Piromed is indicated for use in contexts marked by increased discomfort or tension, such as symptoms related to physical discomfort and systemic imbalance, commonly experienced with headaches or body aches. It is also commonly used to help with symptoms related to heightened physiological activity (fever) and inflammatory or irritative states, such as swelling and discomfort in muscles and joints.

The medication may be part of symptomatic management in conditions involving episodic or fluctuating manifestations, helping to address symptom clusters that may become intense or disruptive. This use provides support that helps ease the overall symptom burden and supports the patient during difficult episodes by easing distress.

“Piromed is applied across domains where additional symptomatic support is needed to maintain a sense of stability when symptoms are more noticeable.”

The medication is commonly used when short-term symptomatic assistance is needed to help manage symptom clusters associated with pain, fever, and inflammatory states.


Quick Fact: Support During Episodic Manifestations

Piromed is relevant in situations where symptoms may intensify temporarily, providing supportive relief when discomfort interferes with routine activities.


Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Piromed is a non-steroidal anti-inflammatory drug (NSAID) used to treat the symptoms of conditions like osteoarthritis and rheumatoid arthritis. However, its use is significantly restricted by official regulatory documents due to serious safety concerns.

Contraindications (Must Not Use)

  • Allergy/Hypersensitivity: Patients with a known allergy to piroxicam or any drug component, or those who have had allergic-type reactions (e.g., asthma, hives) after taking aspirin or other NSAIDs.
  • Gastrointestinal: Patients with active peptic ulcers or a history of gastrointestinal ulceration, bleeding, or perforation.
  • Cardiovascular: Patients in the setting of coronary artery bypass graft (CABG) surgery.
  • Pregnancy: Women at 30 weeks gestation or later in pregnancy due to the risk of harm to the fetus.

Use is Restricted or Avoided

Population/Condition Eligibility Status (Regulatory)**
Pediatric Population (<18 years) Not Approved (Safety/efficacy not established).
Older Adults (>80 years) Avoid Use (Increased risk of serious complications).
Severe Heart/Kidney Failure Avoid Use unless benefits outweigh risks.
Recent Myocardial Infarction Avoid Use unless benefits outweigh the risk of recurrent thrombotic events.
Lactation/Breastfeeding Not Recommended (Safety in infant not established).

Note: Piromed should always be used at the lowest effective dose for the shortest possible duration to minimize potential risks, and is not recommended for first-line treatment due to its overall safety profile.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Piromed (Piroxicam) has officially documented interactions, primarily categorized by regulatory authorities due to combined pharmacodynamic effects and altered drug clearance. All stated interaction patterns are based exclusively on government-approved prescribing information.

Formal Restrictions and Contraindications

Co-administration with Anticoagulants (such as warfarin-type agents) is contraindicated due to the enhanced risk of severe bleeding. Concomitant use with other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), including COX-2 selective NSAIDs and acetylsalicylic acid at analgesic doses, is also contraindicated.

Pharmacodynamic and Efficacy Interactions

Interacting SubstanceOfficial Interaction Outcome
**Oral Corticosteroids / SSRIs / Anti-platelet Agents**Increased risk of serious gastrointestinal complications.
**Diuretics / ACE Inhibitors / ARBs**Diminished antihypertensive or natriuretic effect; risk of renal function deterioration.
**Lithium / Digoxin**Increased serum concentration and prolonged half-life.

Exposure-Altering Interactions

Piroxicam is primarily metabolized by the CYP2C9 enzyme. Individuals who are known or suspected to be poor metabolizers of CYP2C9 substrates may experience abnormally high plasma levels of Piroxicam due to reduced metabolic clearance, a population-specific consideration noted in official labeling. Furthermore, ingestion of excessive alcohol is documented as increasing the risk of serious gastrointestinal complications.

Mechanism of Action

Non-Selective Inhibition of Cyclooxygenase (COX) Enzymes

Piromed's primary mechanism involves the non-selective reversible inhibition of both COX-1 and COX-2 enzymes, which are responsible for converting arachidonic acid into eicosanoid mediators. The drug binds competitively to the active sites of both isoforms, halting the rate-limiting step in the biosynthesis of these substances. This targeted molecular action suppresses the formation of key inflammatory substances, which defines the resulting physiological changes.


Suppression of Prostaglandin-Mediated Signaling

The inhibition of COX leads directly to the systemic suppression of prostaglandins, which are key mediators that sensitize peripheral nociceptors and regulate the body's central thermal set-point. This mechanistic domain influences systems where these mediators dominate, leading to modulation of nociceptive signaling and central thermoregulation.


Non-Eicosanoid Modulation of Cellular Response

Beyond the COX pathway, the mechanism includes an auxiliary cellular domain where the molecule stabilizes lysosomal membranes and reduces the production of destructive reactive oxygen species by neutrophils. This secondary effect influences the cellular activity in local tissue response and contributes to the overall modulation of the inflammatory cascade.

Dosage and Administration Information

Administration Overview

Piromed is typically administered to ensure consistent levels of the medication remain in the bloodstream. The method of administration depends on the specific formulation prescribed, which may include oral or topical applications.

Oral Administration

When taken orally, the medication is usually swallowed with a full glass of water. It is generally recommended to take the dose at the same time each day to maintain a steady routine. Whether the medication should be taken with food or on an empty stomach often depends on individual tolerance and specific medical guidance provided at the time of prescription.

Topical Application

For topical forms of Piromed, the product is applied directly to the affected area of the skin. Before application, the area should be clean and dry. A thin layer is typically spread over the site and rubbed in gently until absorbed. Hands should be washed thoroughly after application unless the hands themselves are the area being treated.

General Considerations

  • Consistency: Maintaining a regular schedule helps in achieving the intended therapeutic effect.
  • Handling: Oral tablets or capsules should be kept in their original packaging until use to protect them from environmental factors like moisture.
  • Missed Applications: If a routine application or dose is overlooked, the regular schedule is typically resumed without doubling the amount used.

Proper storage is essential for maintaining the integrity of the medication. It should be kept at room temperature, away from direct sunlight and excessive heat.

Recent Clinical Evidence

Research evidence / Overview of studies for Piromed

The research evidence for Piromed (Piroxicam) is primarily based on studies that explore how the medicine was evaluated for managing symptoms in certain chronic inflammatory conditions. Regulatory authorities have carefully evaluated this body of work, resulting in specific guidance on the conditions for which the compound has an established research record. The following overview describes the types of research conducted, the outcomes measured, and the existing limitations, adhering strictly to the facts reported in scientific and regulatory literature.

Evidence for Use in Osteoarthritis

Research into Piromed for osteoarthritis (OA) relies on controlled clinical trials that compare symptom measurements to either an inactive substance or to other similar agents. The studies monitored outcomes related to the measurement of physical discomfort, such as pain intensity, and functional ability. The trials documented the measurements of pain and functional scores across the study periods. The existing research structure does not include studies designed to determine if the medicine affects the long-term structural progression of the disease.

Evidence for Use in Rheumatoid Arthritis

For rheumatoid arthritis (RA), the evidence landscape includes multiple Randomized Controlled Trials (RCTs) and subsequent systematic reviews. The research structure, as reviewed by regulators, examined symptoms related to inflammatory states by monitoring outcomes capturing phases of heightened symptom activity, specifically measuring factors like the number of swollen or tender joints. Findings describe patterns observed in the studies where recorded symptomatic measurements were consistent with patterns observed for other nonsteroidal anti-inflammatory agents studied in this context.

Evidence Gaps and Research Uncertainty

Despite a significant number of studies, certain uncertainties remain in the research portfolio for Piromed. Information on long-term effects is not well-characterized in the initial controlled trials alone, and the evidence for specific, less common conditions may be drawn from studies that are limited in size. More critically, regulatory assessments have noted that the research does not suggest a clear difference in measured outcomes compared with some other NSAIDs. These findings resulted in a significant restriction of licensed indications, including the withdrawal of research support for acute pain conditions, reflecting a re-evaluation of the compound’s use based on the total body of evidence.

Key Studies & References

  1. Piroxicam: new restrictions, including specialist initiation (MHRA Drug Safety Update)

Frequently Asked Questions (FAQ)

Common questions about Piromed (FAQ)


Q: What is the main reason doctors prescribe Piromed?

Piromed (Piroxicam) is officially indicated for relieving the signs and symptoms of two specific chronic conditions: osteoarthritis (OA) and rheumatoid arthritis (RA). Official regulatory documents state this as the main purpose for which the medicine is prescribed.


Q: Is Piromed the same kind of medicine as [similar drug name]?

Piromed is classified in official drug information as a nonsteroidal anti-inflammatory drug (NSAID). This means it belongs to the same general category of medicine as several other widely used pain and inflammation relievers.


Q: Can Piromed be used for more than one health condition?

Yes, official regulatory labeling indicates the medicine is prescribed for more than one condition. Specifically, it is approved to help relieve symptoms associated with both osteoarthritis and rheumatoid arthritis.


Q: Is it common to feel [vague side effect like 'dizzy' or 'tired'] when taking Piromed?

Official safety data shows that certain general side effects, such as dizziness and headache, are commonly reported in clinical trials. These effects occurred in approximately 1% to 10% of patients who used the medicine.


Q: Does Piromed interact with common over-the-counter pain relievers?

Regulatory documents state a formal contraindication (a strong warning against using together) for Piromed with certain other common pain relievers. This restriction specifically applies to using it alongside other nonsteroidal anti-inflammatory drugs (NSAIDs) or analgesic doses of aspirin.


Q: Is Piromed safe for use by older adults?

Official guidelines note that older adults face a greater risk of experiencing serious gastrointestinal side effects. Due to this heightened risk, the labeling recommends that prescribers consider dose reductions and requires careful monitoring for potential issues related to kidney, liver, or heart function.


Q: Can Piromed affect my ability to drive or operate machinery?

Yes, official prescribing information suggests that patients exercise caution regarding driving or operating machinery. This is because adverse effects such as dizziness, drowsiness, or vertigo have been reported, which could temporarily affect concentration and coordination.


Q: Is Piromed a habit-forming medication?

Regulatory bodies in the U.S. do not classify Piromed (Piroxicam) as a controlled substance. As an NSAID, this medicine is not associated with abuse potential or the risk of forming dependence.


Q: Do studies suggest Piromed is taken long-term?

Official clinical data shows the drug is effective for both short-term flare-ups and the long-term management of chronic conditions. However, regulatory guidelines emphasize using the lowest effective dose for the shortest duration possible, with the necessity of continuing chronic use subject to periodic review.


Q: If I miss a dose of Piromed, what is generally recommended?

Official patient information generally contains guidance for managing missed doses, which often involves taking the dose when the lapse is noticed. This guidance is based on the standard patient information leaflet.


Q: How is the effectiveness of Piromed measured in clinical trials?

Clinical trials supporting the drug's approval measure effectiveness based on specific outcomes related to its use. Efficacy is generally assessed by measuring pain relief and evaluating the subsidence of inflammation associated with the indicated chronic conditions.


Q: What kind of monitoring might be needed while taking Piromed?

The official prescribing information recommends ongoing monitoring of several key health indicators. These generally include checks of renal (kidney) and liver function, monitoring of blood pressure, and assessing for signs of conditions like anemia (low red blood cell count).


Q: Can Piromed cause weight changes?

Yes, weight changes have been reported as a possible adverse effect. Official patient information notes that unexplained weight gain or swelling, known as edema, in the limbs or abdomen is a potential side effect.


Q: Is Piromed commonly prescribed for people who have [broad comorbidity, e.g., 'kidney issues']?

The medicine can be prescribed to people with impaired liver or kidney function, but this requires caution. Official guidelines state that prescribers should consider reducing the dose for these patients and require careful monitoring of liver and kidney function throughout treatment.


Q: Why do official documents mention [specific caution or warning] for Piromed?

The major cautions exist to inform prescribers and patients about the risk of serious adverse events. Official documents include a Boxed Warning highlighting the potential for severe cardiovascular events (like heart attack or stroke) and serious gastrointestinal complications (like bleeding or perforation).


Q: What is the risk of a serious allergic reaction to Piromed?

Official labeling documents the potential for patients to experience serious hypersensitivity reactions. These reactions can include anaphylactic-like responses and rare, but severe, skin conditions such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).


Q: Does Piromed have different brand names or generics?

Yes, the active ingredient in Piromed is Piroxicam, which is the generic name. It is available under this generic name and has also been marketed globally under various brand names, such as Feldene.


Q: Can Piromed be taken with cold and flu medications?

The co-administration of this medicine with over-the-counter cold or flu remedies may present a risk. Official warnings state that co-administration with other NSAIDs or aspirin, common components of many multi-symptom cold preparations, is contraindicated.


Q: What happens to Piromed in the body (pharmacokinetics)?

After being taken orally, the medicine is well absorbed into the body. It is primarily broken down (metabolized) by a specific liver enzyme, CYP2C9, and then eliminated (excreted) from the body in both the urine and feces.


Q: Can young adults or teenagers use Piromed?

Official guidelines state that use and dosage for adolescents and children must be determined by a healthcare provider. The medicine has been used for specific conditions, such as certain types of juvenile idiopathic arthritis, in patients as young as two years old.


Q: How often do patients typically experience [common side effect]? (General prevalence question)

Official safety data from clinical trials provides an estimate for common adverse reactions. The most frequently reported side effects, which include issues like nausea, constipation, and dizziness, typically occurred in approximately 1% to 10% of patients.


Q: Why is Piromed sometimes not suitable for people with certain heart conditions?

Official labeling states the medicine is contraindicated for the treatment of pain following coronary artery bypass graft (CABG) surgery. It is also generally avoided in those with severe heart failure due to regulatory warnings about the potential for fluid retention and the risk of serious cardiovascular events.


Q: Is Piromed safe to take if I am planning a pregnancy in the future?

Official prescribing information notes that the medicine has the potential to delay or temporarily prevent ovulation, though this effect is generally reversible. For this reason, official guidance states that the medicine should be avoided when actively attempting to conceive.


Q: Does Piromed require any special storage conditions?

The official product monograph specifies that the medicine must be stored at a controlled room temperature, generally between 15 °C and 30 °C (59 °F and 86 °F). The container must be kept tightly closed to maintain its quality and stability.


Q: What information is available about the long-term safety profile of Piromed?

Official warnings clearly state that the risk of serious cardiovascular (CV) and gastrointestinal (GI) thrombotic events can increase the longer the medicine is used. The guidelines state that prescribers should use the drug for the shortest possible duration consistent with treatment goals.


Q: Why do some people say Piromed did not work for them?

Based on clinical data, a person may not feel the full benefit of the medicine right away. Studies indicate that while the medicine begins working immediately, the full therapeutic effect of chronic use may require up to two weeks of continuous use before it can be accurately assessed.


Q: How long does Piromed stay in the system after the last dose?

Piromed has a relatively long half-life, meaning it takes a long time for the body to eliminate half of the dose. Official data states the elimination half-life is approximately 50 hours, which means that complete clearance from the body takes several days after the last dose is taken.


Q: What are the official guidelines regarding the use of Piromed during breastfeeding?

Official guidance generally does not recommend using the medicine while breastfeeding. This is a precautionary measure because the clinical safety data regarding the medicine’s effects on a breastfed infant have not been definitively established in regulatory reviews.


Q: Does the efficacy of Piromed change if it's taken at different times of the day?

The medicine is dosed once per day, a regimen supported by its long half-life in the body. This characteristic allows it to maintain relatively stable blood concentrations over a full 24-hour period, meaning efficacy is not generally dependent on a specific time of day.


Q: Is Piromed intended to be a cure, or is it a long-term management treatment?

Official prescribing information defines the medicine as a treatment for the relief of signs and symptoms of chronic conditions. It is not intended to be a cure, but rather an established option for the long-term management of its approved indications.


Q: Do regulatory bodies classify Piromed as a high-risk medication?

Regulatory bodies classify the medicine with significant cautions. The official label contains a Boxed Warning that highlights the risk of serious, potentially life-threatening, cardiovascular and gastrointestinal adverse events.


Q: What kind of studies support the primary use of Piromed?

The primary uses of the medicine are supported by evidence obtained from controlled clinical trials. These studies established the efficacy of the medicine for the long-term management of chronic inflammatory conditions, such as osteoarthritis and rheumatoid arthritis.


Q: Can stress or lifestyle factors affect how Piromed works?

Official safety labeling specifically documents that the ingestion of excessive alcohol may increase the risk of serious gastrointestinal complications. No other general lifestyle factors are typically documented as affecting how the medicine works.


Q: Is it typical for Piromed to be used in combination with other treatments?

In clinical trials, the medicine has been administered concurrently with certain other treatments, such as fixed doses of gold or corticosteroids. However, official labeling mandates avoiding its use in combination with many other drugs, particularly other NSAIDs and anticoagulants.


Q: Are there specific criteria patients must meet to be considered eligible for Piromed?

Eligibility for the medicine is generally determined by the absence of specific conditions or contraindications. Official regulatory information lists criteria such as not having a known hypersensitivity to the drug or other NSAIDs, and not having a history of severe gastrointestinal issues.

How should Piromed be stored and disposed of?

How to Store and Dispose of Piromed

Storage and disposal of Piromed (Piroxicam) must strictly follow the conditions defined in official regulatory labeling to ensure drug stability and public safety.

Storage Requirements

Condition Instruction
Temperature Store at controlled room temperature (20°C to 25°C). Do not freeze.
Container Keep in the original container, tightly closed.
Protection Protect from excess heat and moisture.
Child Safety Store out of the sight and reach of children.

Disposal Instructions

Unused or expired Piromed should be disposed of through an authorized drug take-back program. If a take-back option is not available, the medicine should be mixed with an undesirable substance (such as used coffee grounds) and placed in a sealed container for household trash. The medication must not be flushed down a sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Piromed found in:

A-Z Index: